All Posts

Upper Biotech is pleased to announce its participation in APSEV2026 / JSEV2026, taking place on October 22–23, 2026, at JP TOWER Hall & Conference in Tokyo, Japan. Bringing together researchers and professionals in the extracellular vesicle (EV) field, this event provides an opportunity to exchange insights on EV research, isolation technologies, characterization, and emerging applications. Discover the ExoFaster-600 Automated EV Isolation Platform At Booth 5, Upper Biotech w

Upper Biotech is pleased to announce its participation in MEDICA 2026, the world's leading international trade fair for the medical sector, held in Düsseldorf, Germany from 16–19 November 2026. This year, we will be exhibiting in partnership with UK HiMed Innovation at the United Kingdom Hall, Booth 16 G13-5. Our presence at MEDICA reflects Upper Biotech's continued commitment to supporting the global healthcare and life sciences community. Visitors to our stand will be able

We are looking forward to the 8th GEIVEX Symposium in Bilbao, taking place 6‑9 October 2026.

Introduction Compared with EVs from blood or cell culture media, milk-derived EVs feature abundant sources, high yield and excellent in vivo tolerance, supporting both basic mechanism research and translational delivery applications. Nevertheless, commercial milk processing and inconsistent purification protocols can alter vesicle integrity, cargo-loading capacity and biological activity, leading to poor experimental reproducibility. Standardized material screening and multi-

1. Overview This application note evaluates the performance of ExoFaster-500’s dedicated built-in continuous processing mode for repeated loading of identical human plasma samples. Five sequential 1 mL plasma aliquots were loaded under the automatic continuous workflow, which integrates PBS column washing and re-equilibration between each run without manual intervention. NTA particle quantification paired with BCA protein testing, demonstrate highly consistent chromatographic

1. Overview This note compares two mainstream EV extraction workflows: ultracentrifugation (UC) and ultrafiltration pre-concentration combined with size-exclusion chromatography (UF+SEC) using the ExoFaster-500 system. Conditioned media from three cell lines were tested via multi-dimensional characterization to provide method selection guidance. 2. Materials & Protocols 2.1 Sample Preparation Conditioned media of ESC, HSC and NK cells in logarithmic phase were collected. Seri

Upper Biotech will showcase its latest ExoFaster™ series at ISEV 2026, the world’s largest annual extracellular vesicle conference, held April 23–26 at the Puerto Rico Convention Center. Visit us at Booth 38 — we look forward to meeting you there. The ExoFaster™ concept redefines extracellular vesicle isolation with a fast, automated, and integrated solution designed for real-world EV research. Visit us at Booth # 38 for: • Live demo of ExoFaster-500™ • Win a free ExoFaster™

1. Overview This application note evaluates the performance of ultrafiltration (UF) pre-concentration prior to size-exclusion chromatography (SEC) isolation of extracellular vesicles (EVs) from mouse quadriceps tissue conditioned medium using the ExoFaster-500 platform. EV yields and purity from un-concentrated crude conditioned medium and UF-concentrated samples were compared via UV absorbance profiling (A260/A280) and nanoparticle tracking analysis (NTA), demonstrating that

On 16 April 2026, we bought our EV Extraction Platform, ExoFaster-500 to Midlands Innovation Extracellular Vesicles Conference at University of Nottingham. During the event, we have introduce exosome and a live demo of our ExoFaster-500.

1. Overview This application note validates a complete workflow for extracellular vesicle (EV) isolation from E. coli culture medium, combining sequential centrifugal clarification, ultrafiltration (UF) pre-concentration and size-exclusion chromatography (SEC) on the ExoFaster-500 platform. We evaluated the impact of different pre-concentration factors (30×, 125×, 375×) on SEC separation performance, EV yield, and protein contaminant detection. 2. Experimental Protocol 2.1 Sa